Intracranial Atherosclerosis Enrolling by Invitation Phase 1 Trials for Ferumoxytol (DB06215)

IndicationStatusPhase
DBCOND0040495 (Intracranial Atherosclerosis)Enrolling by Invitation1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03084523Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRIDiagnostic